Inactive Instrument

Flying Brands Ltd. London S.E.

Equities

FBDU

GB0003437059

Healthcare Facilities & Services

Flying Brands Ltd. : Office of Fair Trading - Merger Update

May 28, 2012 at 11:20 am EDT

MarketScreener.com By The editorial team

The OFT has published the text of its decision on the completed acquisition by United Online Inc. of the gifts division business of Flying Brands Limited which was cleared. This decision can be found on the Office of Fair Trading's website atwww.oft.gov.uk.

In the event of media enquires please call the OFT Press Office on 020 7211 8899.

This information is provided by RNS

The company news service from the London Stock Exchange

RNS news service provided by Hemscott Group Limited.

distributed by

Latest news about Flying Brands Ltd.

IQ-AI's Broker Exercises Option to Buy Shares in Placing	Feb. 26	MT
IQ-AI Plans Share Placing to Advance Oral Anti-tumor Agent Development	Feb. 22	MT
IQ-AI shares sink on discounted placing fundraise	Feb. 22	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	Feb. 09	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	Feb. 09	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	Feb. 02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	Feb. 02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	Jan. 10	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	Jan. 10	MT
IQ-AI Subsidiary’s Glioblastoma Therapy Obtains Fast-Track Designation From US FDA	Dec. 19	MT
IQ-AI firm gets US FDA fast-track status for oral gallium maltolate	Dec. 19	AN
IQ-AI's Imaging Biometrics Discloses Positive Results in Early-stage Study of Potential Brain Cancer Treatment	Dec. 05	MT
IQ-AI stock rises on positive interim results from glioblastoma trial	Dec. 05	AN
IQ-AI Unit Seeks Pediatric Rare Disease Designation for Brain Tumor Treatment	Nov. 08	MT
IQ-AI says Imaging Biometrics submits paediatric rare disease request	Nov. 08	AN
IQ-AI Applies for FDA Pediatric Rare Disease Designation	Nov. 08	CI
IQ-AI subsidiary "central" to "landmark" brain cancer study	23-10-18	AN
IQ-AI subsidiary wins orphan drug designation from US FDA	23-10-09	AN
IQ-AI's Atypical Teratoid Rhabdoid Tumor Treatment Gains US FDA Orphan Drug Designation	23-10-09	MT
IQ-AI Halts Trading on OTCQB Venture Market in US; London Shares Up 13%	23-09-19	MT
IQ-AI Unit’s Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners	23-09-08	MT
IQ-AI notes vindication of subsidiary's reduced gadolinium approach	23-09-08	AN
Mayo Clinic Reverts IQ-AI Shares as IB Trax Deal Closes	23-08-18	MT
IQ-AI Shares Up 18% as Unit Strikes Commercial Deal with GE HealthCare	23-08-18	MT
IQ-AI shares jump on subsidiary's GE Healthcare deal	23-08-18	AN

Chart Flying Brands Ltd.

Duration

Period

More charts

Company Profile

IQ-AI Limited is a Jersey-based company, which is engaged in the provision of clinical treatments to patients in the field of medical imaging diagnostics, based on technology. The Company operates through two segments: holding company expenses and medical software. Its subsidiaries include Imaging Biometrics, LLC and Stone Checker Software Limited. Imaging Biometrics, LLC is a healthcare imaging software company. In addition to providing regulatory consulting services, Imaging Biometrics, LLC supplies medical technology solutions and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention.

Sector

Healthcare Facilities & Services

Calendar

2024-04-29 - Q4 2023 Earnings Release (Projected)

More about the company

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-17.89%	8.36B
RADNET, INC.	+40.49%	3.6B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-32.64%	2.73B
SYNLAB AG	-7.88%	2.47B
DR. LAL PATHLABS LIMITED	-7.87%	2.32B
NEOGENOMICS, INC.	-14.40%	1.77B
FLEURY S.A.	-18.74%	1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.19%	1.22B
METROPOLIS HEALTHCARE LIMITED	+5.57%	1.09B

Medical & Diagnostic Laboratories